What are the significant drug interactions with nifedipine, including CYP3A4 inhibitors and inducers and other agents that may cause additive hypotensive effects?

Significant Drug Interactions with Nifedipine

Nifedipine has critical drug interactions primarily through CYP3A4 metabolism, with strong CYP3A4 inhibitors increasing nifedipine exposure by 2-5 fold and potentially causing severe hypotension, while strong CYP3A4 inducers like rifampin can reduce nifedipine levels by up to 97%, rendering it ineffective. 1

CYP3A4 Inhibitors: Dose Reduction Required

Strong CYP3A4 inhibitors significantly increase nifedipine exposure and require careful monitoring with dose reduction:

Contraindicated or Avoid:

• Azole antifungals (ketoconazole, itraconazole, voriconazole): Increase nifedipine AUC by 2.5-fold and Cmax by 1.7-fold 1, 2
• HIV protease inhibitors (ritonavir, indinavir, nelfinavir, saquinavir): Ritonavir increases nifedipine Cmax by 17.92-48.85-fold and AUC by 63.30-84.01-fold, causing severe hypotension (>40 mmHg SBP drop) 3
• Combination of multiple CYP3A4 inhibitors (e.g., clarithromycin plus voriconazole): Synergistic potentiation can cause ischemic acute kidney injury from excessive hypotension 4

Use with Caution and Monitor:

• Macrolide antibiotics: Clarithromycin increases AUC 1.5-fold and Cmax 1.4-fold; erythromycin increases both by 1.3-fold 5, 1
• Calcium channel blockers:
  • Diltiazem increases nifedipine AUC by 2.2-3.1-fold and Cmax by 1.7-2.0-fold 6, 1
  • Verapamil similarly inhibits nifedipine metabolism 1
• Antiarrhythmics: Quinidine increases nifedipine Cmax by 2.3-fold and AUC by 1.37-fold 1
• Cimetidine: Increases nifedipine AUC by 1.52-2.01-fold and Cmax by 1.60-2.02-fold 1
• Grapefruit juice: Avoid consumption as it increases nifedipine plasma concentrations 1

Management approach: Start nifedipine at the lowest available dose when co-administered with CYP3A4 inhibitors. Monitor blood pressure closely and adjust dose downward as needed. 1

CYP3A4 Inducers: Contraindicated

Strong CYP3A4 inducers dramatically reduce nifedipine efficacy:

• Rifampin: Reduces nifedipine Cmax by 95% and AUC by 97% - contraindicated 1
• Anticonvulsants (phenytoin, phenobarbital, carbamazepine): Reduce nifedipine AUC and Cmax by approximately 70% 1
• St. John's Wort: Reduces bioavailability unpredictably 1

Management: Do not use nifedipine with strong CYP3A4 inducers. Consider alternative antihypertensive therapy. 1

Additive Hypotensive Effects

Nifedipine's vasodilatory effects are additive with other blood pressure-lowering agents:

Beneficial Combinations:

• ACE inhibitors (e.g., captopril, benazepril): Additive blood pressure reduction; ACE inhibitors counteract nifedipine-induced tachycardia 7, 1
• Beta-blockers: Well-tolerated combination with additive antihypertensive effects 8, 1
• Angiotensin-II receptor blockers (irbesartan, candesartan): No significant pharmacokinetic interaction; additive blood pressure lowering 1

Monitor for Excessive Hypotension:

• Alpha-blockers (prazosin, alfuzosin): Risk of orthostatic hypotension 9
• Other vasodilators: Monitor blood pressure closely 10

Clinical pearl: The combination of nifedipine with ACE inhibitors or ARBs is rational and commonly used, as they have complementary mechanisms of action. 8

Other Significant Interactions

Digoxin:

• Nifedipine may increase digoxin levels; monitor digoxin concentrations when initiating or adjusting nifedipine 11, 9

Tacrolimus:

• Nifedipine inhibits tacrolimus metabolism, reducing required tacrolimus dose by 26-38%; monitor tacrolimus blood levels 1

Gastric pH Modifiers:

• Omeprazole/PPIs: May increase nifedipine exposure through CYP3A4 inhibition, though clinical significance is modest 1, 12
• Antacids: Administer at least 2 hours before or after nifedipine to avoid interference with absorption 13

Critical Monitoring Parameters

When nifedipine is combined with interacting drugs:

• Blood pressure: Monitor closely for hypotension or loss of efficacy
• Heart rate: Particularly with CYP3A4 inhibitors
• Renal function: Severe hypotension can cause acute kidney injury 4
• Peripheral edema: Dose-dependent effect (8% at 30 mg, 19% at 90 mg daily) 1

Common pitfall: Prescribing multiple CYP3A4 inhibitors simultaneously with nifedipine creates synergistic interactions that can cause life-threatening hypotension and organ injury. Always review the complete medication list before initiating or adjusting nifedipine. 4